| Pharmaceutical active ingredients: |
| Sodium Pyrophosphate Decahydrate |
| Available forms, composition and doses of Angiocis TCK-7: |
| Injectable; Injection; Sodium Pyrophosphate Decahydrate 20.12 mg |
| Angiocis TCK-7 medical category: |
| Human:Buffering agentsDispersing agentsEmulsifiersFood additivesThickening agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering PharmaCIS Bio International |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Whit-Pro | Sodium Propionate | Unidentified Pharmaceutical Company |
| Propiazol | Sodium Propionate; Sulfathiazole Sodium | Istituto Biochimico Sperimentale |
| Ajidew N-50 | Sodium Pyroglutamate | Unidentified Pharmaceutical Company |
| Phosphotex | Sodium Pyrophosphate | Unidentified Pharmaceutical Company |
| Ren Hematocis | Sodium Pyrophosphate | REM, Brazil |
| Kit for Preparation of Tin Pyrophospate | Sodium Pyrophosphate Decahydrate | MDS Nordion |
| TCK-7 Angiocis | Sodium Pyrophosphate Decahydrate | CIS Bio International; REM, Brazil |
| Hydromol Cream | Sodium Pyrrolidone Carboxylate | Alliance Pharmaceuticals; Allphar Services; Ferndale Laboratories |
| Colidosan | Sodium Ricinoleate | Unidentified Pharmaceutical Company |
| Soricin | Sodium Ricinoleate | Unidentified Pharmaceutical Company |